Last reviewed · How we verify
NCT03625908
Optical CoherenCe Tomography-gUided Coronary Intervention in Patients With Complex lesIons: a Randomized Controlled Trial (OCCUPI Trial)
NA trial testing OCT-guided PCI in Coronary Artery Disease in 1,604 participants. Completed in 12 October 2023.
12 October 2023
Quick facts
| Lead sponsor | Yonsei University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 1,604 |
| Start date | 9 January 2019 |
| Primary completion | 12 October 2023 |
| Estimated completion | 12 October 2023 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- OCT-guided PCI
- Angiography-guided PCI
Conditions studied
- Coronary Artery Disease — all drugs for Coronary Artery Disease →
Sponsor
Yonsei University
Who can join
Adults 19 to 85, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There is no definite conclusive work about the benefit of OCT-guided PCI, which should be determined in complex PCI, assuming better stent optimization by OCT. In the study, we will explore the clinical implication of OCT-guided PCI of complex lesions.
Publications & conference data
8 peer-reviewed publications reference this trial (live from Europe PMC):
-
Intracoronary optical coherence tomography: state of the art and future directions.
Ali ZA, Karimi Galougahi K, Mintz GS, Maehara A, et al · · 2021 · cited 87× · PMID 34110288 · DOI 10.4244/eij-d-21-00089 -
Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention for patients with complex lesions (OCCUPI): an investigator-initiated, multicentre, randomised, open-label, superiority trial in South Korea.
Hong SJ, Lee SJ, Lee SH, Lee JY, et al · · 2024 · cited 49× · PMID 39236729 · DOI 10.1016/s0140-6736(24)01454-5 -
Sex Differences in Cardiovascular Outcomes of Intravascular Imaging-Guided PCI: A Meta-Analysis of Randomized Controlled Trials.
Ezenna C, Ibrahim S, Ramesh P, Ismayl M, et al · · 2025 · cited 3× · PMID 40829371 · DOI 10.1016/j.jacadv.2025.102076 -
Widespread Use of Imaging-Guided PCI in Asia: Time for Extended Application.
Kim Y, Kim JH, Hong SJ, Kim HK, et al · · 2024 · cited 3× · PMID 39371623 · DOI 10.1016/j.jacasi.2024.07.003 -
OCT-Guided PCI According to Lesion Length and Vessel Diameter: Post Hoc Analysis of OCCUPI Trial.
Roh JW, Lee OH, Heo SJ, Im E, et al · · 2026 · PMID 41999373 · DOI 10.1016/j.jacasi.2026.02.023 -
Optical coherence tomography-guided percutaneous coronary intervention in acute coronary syndrome patients with complex lesions: a subgroup analysis of the randomised OCCUPI Trial.
Lee YJ, Kim Y, Lee OH, Cho DK, et al · · 2025 · PMID 41489717 · DOI 10.4244/eij-d-25-00478 -
Optical Coherence Tomography-Guided vs. Angiography-Guided Percutaneous Coronary Intervention for Complex Coronary Lesions: A Systematic Review and Meta-Analysis.
Shuja MH, Ahmed M, Hannat R, Khurram L, et al · · 2025 · PMID 40804871 · DOI 10.3390/diagnostics15151907 -
Current evidence for prognostic benefit of intravascular imaging-guided percutaneous coronary intervention in chronic total occlusion intervention.
Hong D, Kim SE, Lee SH, Lee SJ, et al · · 2024 · PMID 38419334 · DOI 10.3904/kjim.2023.420
Verify or expand the search:
- PubMed search for NCT03625908
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of OCT-guided PCI
Trials testing the same drug.
- NCT06339021 — OCT or Angiography Guided De-escalation of DAPT · EARLY_PHASE1 · not yet recruiting
- NCT06154395 — Study on the Improvement of Myocardial Microcirculation After Acute Anterior Myocardial Infarction · NA · recruiting
- NCT05493904 — PREcise Percutaneous Coronary Intervention for Stent OptimizatION in Treatment of COMPLEX Lesion (PRECISION-COMPLEX) · NA · active not recruiting
- NCT04444037 — Impact of OCT Imaging on Decision Making During PCI in ACS Patients · completed
Other recruiting trials for Coronary Artery Disease
Currently open trials in the same condition.
- NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
- NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
- NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Other Yonsei University trials
Trials by the same sponsor.
- NCT07547592 — Gemcitabine and Docetaxel With or Without Bevacizumab (Onbevzi) for Soft Tissue Sarcoma · Phase 2 · not yet recruiting
- NCT07524101 — Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD · NA · not yet recruiting
- NCT07506629 — Adductor Canal Block Methods in Bilateral Total Knee Arthroplasty · NA · not yet recruiting
- NCT07515716 — Effects of High Flow Humidified Oxygen on Umbilical Artery Acid-base Balance in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
- NCT07507188 — Collaborative Clinical-translational Cohort of Amivantamab Plus Lazertinib and Amivantamab Plus Chemotherapy in Patients · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03625908 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yonsei University
- Last refreshed: 14 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03625908.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing